Cargando…
Maternal Immune Cell and Cytokine Profiles to Predict Cardiovascular Risk Six Months after Preeclampsia
Women who develop preeclampsia (PE) are at high risk for cardiovascular disease (CVD). Early identification of women with PE who may benefit the most from early cardiovascular risk screening and interventions remains challenging. Our objective was to assess whether cytokine and immune cell profiles...
Autores principales: | Murphy, Malia S. Q., Benton, Samantha J., Cox, Brian, Nerenberg, Kara, McComb, Scott, Krishnan, Lakshmi, Weeratna, Risini D., Paré, Jean-François, Dingwall-Harvey, Alysha L. J., Bainbridge, Shannon A., Gruslin, Andrée, Gaudet, Laura M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317739/ https://www.ncbi.nlm.nih.gov/pubmed/35887949 http://dx.doi.org/10.3390/jcm11144185 |
Ejemplares similares
-
A simplified function-first method for the discovery and optimization of bispecific immune engaging antibodies
por: Shepherd, Alex, et al.
Publicado: (2023) -
Fibrinogen-Like Protein 2-Associated Transcriptional and Histopathological Features of Immunological Preeclampsia
por: Robineau-Charette, Pascale, et al.
Publicado: (2020) -
An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2017) -
From mice to women: the conundrum of immunity to infection during pregnancy
por: Krishnan, Lakshmi, et al.
Publicado: (2013) -
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocol
por: Lalu, Manoj M., et al.
Publicado: (2023)